Metagenomi Technologies, a genetic medicines company, registered with the SEC on Jan. 5 to list its shares on the Nasdaq. The size of the IPO has not been announced. The Emeryville, California-based company is advised by Goodwin Procter partners Mitchell Bloom, Edwin O'Connor and Justin Platt. The underwriters, led by JPMorgan Chase and Jefferies Financial Group, are represented by Davis Polk & Wardwell partners Yasin Keshvargar and Richard Truesdell.
Biotech & Pharmaceuticals
January 08, 2024, 11:04 AM